University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, 27517, United States
NCT Number: NCT04053413
This is pilot quasi-experimental study of women with one or two prior cesarean deliveries who are now pregnant and eligible for a trial of labor after cesarean delivery, to assess whether a decision aid, providing knowledge about trial of labor (VBAC) and planned repeat cesarean delivery can improve the birth options decision-making process for patients.
Participants are screened for eligibility through electronic health records. Once an individual is screened eligible, and email invite is sent providing information about the study and assessing the interest in participation. An on-line consent is completed and women are entered sequentially into the usual care group and then through further recruitment, another sample of women are entered into the decision aid group. The primary outcome is satisfaction with the shared decision-making process with their provider.
Looking for future studies?
Notify Me21 year and older
Female
Interventional
Not applicable
Chapel Hill, North Carolina, 27517, United States
Once a potential participant is screened eligible, completes the on-line informed consent, they are officially enrolled in the study and sent a link confirming their enrollment and the study group in which they have been assigned. Participants are sequentially enrolled in the study with enrollment first into the usual care group. Once enrollment in the usual care group is complete, enrollment into the decision aid group will occur.
The study includes two non-randomized groups:
Arm 1 (Usual care group): Women in this group will undergo usual care and complete the survey questions on knowledge of risks and benefits of TOLAC (also referred to as VBAC) and planned repeat cesarean (PRCS), certainty of their decision, and involvement in the decision for trial of labor (TOLAC) or repeat cesarean delivery.
Arm 2: (Decision aid group- group receiving the decision tool): Women in this group will receive a decision aid prior to undergoing counseling by their physician. Following completion of the decision aid and physician counseling, they will complete a series of survey questions to assess their knowledge of the risks and benefits of TOLAC and PRCS, certainty of their decision, and involvement in the decision for repeat cesarean or TOLAC.
The decision aid group will be compared with women who do not receive the decision aid (usual care group).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The decision aid is a series of web pages that includes videos, questions, and evidence-based information. The decision aid is designed to help women think about what matters to them and what questions they may have for their doctor or midwife. At the end, they receive a summary of which way they are leaning and what matters most to them.
Time frame: Up to 6 months prior to delivery
This is a measure of the patient's involvement in the decision. 1 point is assigned for discussing the pros 'a lot' or 'some'; 1 point is assigned for discussing the cons 'a lot' or 'some'; 1 point is assigned for responding 'yes' if the provider explained the options; and 1 point is assigned for responding 'yes' that the provider asked the patient what treatment she wanted. The tool's score range is 0-4. A higher score indicates more involvement in the decision.
Time frame: Date of Admission
Intended mode of delivery (repeat cesarean or vaginal) prior to actual delivery
Time frame: Up to 72 hours after delivery
Actual method of delivery (repeat cesarean or vaginal delivery)
Time frame: Up to 72 hours after delivery
Number of complication events: maternal postpartum hemorrhage, infection, fetal admission to neonatal intensive care unit.
Time frame: Up to 6 months prior to delivery
Participant responses are: 1) repeat cesarean delivery, 2) vaginal delivery and 3) undecided
University of North Carolina, Chapel Hill
Other
Pilot Study to Assess the Effectiveness of a Decision Tool for Cesarean Delivery vs. Trial of Labor
Acronym: B-READY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02775747
Cicatrix, Fibrosis
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT02827591
Cicatrix, Fibrosis
Halle, Saxony-Anhalt, Germany
View Trial DetailsNCT02827604
Cicatrix, Fibrosis
Halle, Saxony-Anhalt, Germany
View Trial DetailsNCT02703519
Cicatrix, Complications; Cesarean Section, Wound, Dehiscence
Halle, Saxony-Anhalt, Germany
View Trial Details